Sabril Tablet, Film Coated
Product Images NDC 67386-111

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sabril (NDC 67386-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lundbeck Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

The Chemical Structure Of Vigabatrin. (Sabril Tablets 1)

The Chemical Structure Of Vigabatrin. (Sabril Tablets 1)
FDA Label Image

Figure 1. Percent Reduction From Baseline In Seizure Frequency (Sabril Tablets 2)

Figure 1. Percent Reduction From Baseline In Seizure Frequency (Sabril Tablets 2)
FDA Label Image

Figure 2. Percent Reduction From Baseline In Seizure Frequency (Sabril Tablets 3)

Figure 2. Percent Reduction From Baseline In Seizure Frequency (Sabril Tablets 3)
FDA Label Image

Principal Display Panel Ndc 67386-111-01 Sabril® (vigabatrin) Tablets 500 mg Dispense The Enclosed Medication Guide With Each Presctiption. Rx Only 100 Tablets (Sabril Tablets 4)

Principal Display Panel Ndc 67386-111-01 Sabril® (vigabatrin) Tablets 500 mg Dispense The Enclosed Medication Guide With Each Presctiption. Rx Only 100 Tablets (Sabril Tablets 4)
This is a medication package of Sabril (vigabatrin) tablets. The recommended storage temperature is between 20-25°C (68-77°F), it should be dispensed in a USP tight container. Each tablet contains 500mg of vigabatrin. The recommended dosage can be found in the package insert. Sabril is a registered trademark of Lundbeck.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.